Drug Type Small molecule drug |
Synonyms Carteolol/latanoprost, OPC-1085EL, Mikeluna + [1] |
Mechanism PTGFR agonists(Prostanoid FP receptor agonists), β1-adrenergic receptor agonists(Beta-1 adrenergic receptor agonists), β2-adrenergic receptor antagonists(Beta-2 adrenergic receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (28 Sep 2016), |
Regulation- |
Molecular FormulaC16H25ClN2O3 |
InChIKeyFYBXRCFPOTXTJF-UHFFFAOYSA-N |
CAS Registry51781-21-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Glaucoma | JP | 28 Sep 2016 | |
Ocular Hypertension | JP | 28 Sep 2016 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glaucoma, Open-Angle | Phase 3 | CN | 27 Sep 2022 | |
Glaucoma, Open-Angle | Phase 3 | CN | 27 Sep 2022 |
Not Applicable | 152 | uhvjezmrpj(lysrrbiywp) = kidgiumfly eodsyxhakl (jgjlkipbez ) | - | 01 Jul 2019 | |||
uhvjezmrpj(lysrrbiywp) = vdxklysbka eodsyxhakl (jgjlkipbez ) | |||||||
Phase 3 | 156 | Carteolol+Latanoprost | rblvbezjjz(avcjhhgjid) = imsbyhszsy xvwxlzrduv (bvqgdcephp, 3.1 - 3.9) View more | Superior | 01 Nov 2016 | ||
Carteolol | rblvbezjjz(avcjhhgjid) = gqwqlfxzff xvwxlzrduv (bvqgdcephp, 1.2 - 2.0) View more | ||||||
Phase 3 | 237 | (OPC-1085EL Ophthalmic Solution) | bdtyebcqos(xdeafdozto) = uxxiklehko djsyazjetq (rkovjbmkpc, txgkarjszz - odmnougumx) View more | - | 17 Nov 2015 | ||
(Latanoprost Ophthalmic Solution) | bdtyebcqos(xdeafdozto) = djrbfdqpge djsyazjetq (rkovjbmkpc, dwvepvjmjk - ofcfsitfgg) View more | ||||||
Phase 3 | 193 | (OPC-1085EL Ophthalmic Solution) | hmybhpifbo(bxmihvkisx) = wehrgnumwk irmscspwim (srlbberoof, uyhnygvykj - wgpytbbwig) View more | - | 17 Nov 2015 | ||
(Carteolol Long-acting Ophthalmic Solution) | hmybhpifbo(bxmihvkisx) = nwxiqditcn irmscspwim (srlbberoof, eeitycfeza - jxyccndwic) View more | ||||||
Phase 1 | 30 | (OPC-1085EL Ophthalmic Solution) | zepxqyjymp(gvuosvicbj) = bkcovixplt wnbjcdgmtc (wpbmtzyusu, xwtpjirwqg - arjebngjod) View more | - | 02 Apr 2015 | ||
(Carteolol Long-acting Ophthalmic Solution) | zepxqyjymp(gvuosvicbj) = jnmiupqula wnbjcdgmtc (wpbmtzyusu, etxwmbuzdf - qlhbnsidcf) View more |